Surgical Treatment of Atrial Fibrillation
Atrial fibrillation (Afib) is the most common irregular heart rhythm in the United States, affecting about 2.5 million people. More than 160,000 new cases of atrial fibrillation are diagnosed each year. The goals of treatment for atrial fibrillation include a return to normal heart rhythm, control of heart rate, and prevention of blood clots and strokes.
Using the very latest technology, we can now extend treatment to virtually all patients with Afib. Patients considered for surgical ablation fall into two groups: (1) Patients with isolated atrial fibrillation, who may be candidates for keyhole or minimally invasive treatment approaches (Robotic or thorascopic) or the Maze procedure or (2) Patients with atrial fibrillation who require heart surgery for other reasons, most commonly coronary artery disease or valvular heart disease. Surgeons may perform either a classic Maze procedure or a modified Maze procedure.